Page last updated: 2024-08-16

sb 206553 and 8-hydroxy-2-(di-n-propylamino)tetralin

sb 206553 has been researched along with 8-hydroxy-2-(di-n-propylamino)tetralin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D1
Bienkowski, P; Bucki, A; Jaśkowska, J; Kazek, G; Kowalski, P; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Mitka, K; Pawłowski, M; Siwek, A; Wasik, A; Wesołowska, A1
Berthold, EC; Canal, CE; Chen, Y; Gamez-Jimenez, LR; Hampson, AJ; Hiranita, T; Kamble, SH; King, TI; León, F; Lopera-Londoño, C; McCurdy, CR; McMahon, LR; Mottinelli, M; Obeng, S; Patel, A; Restrepo, LF; Sharma, A1
Caccia, S; De Deurwaerdère, P; Lucas, G1

Other Studies

4 other study(ies) available for sb 206553 and 8-hydroxy-2-(di-n-propylamino)tetralin

ArticleYear
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 370, Issue:2

    Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists

2004
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
    Journal of medicinal chemistry, 2014, Jun-12, Volume: 57, Issue:11

    Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; CHO Cells; Cricetulus; Dementia; Dopamine D2 Receptor Antagonists; HEK293 Cells; Humans; Male; Models, Molecular; Motor Activity; Radioligand Assay; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Sulfonamides

2014
Activity of
    Journal of medicinal chemistry, 2021, 09-23, Volume: 64, Issue:18

    Topics: Analgesics; Animals; Behavior, Animal; Female; HEK293 Cells; Humans; Male; Nociceptive Pain; Rats, Sprague-Dawley; Receptors, Serotonin; Secologanin Tryptamine Alkaloids

2021
The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
    Neuropharmacology, 2000, Apr-03, Volume: 39, Issue:6

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Citalopram; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluorobenzenes; Haloperidol; Indoles; Male; Microdialysis; Phenols; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists

2000